Altius Institute for Biomedical Sciences is an independent, nonprofit research organization created to pursue discovery at the leading edge of modern biomedicine.  


Enabled by a visionary founding investment from GlaxoSmithKline, Altius is creating a new paradigm to catalyze ground-breaking biological innovation, integrate molecular and computational science and engineering, and empower fundamental technology development to radically accelerate the leap from basic to medical breakthroughs.




Altius is combining automated functional genomics, genome engineering, advanced imaging, and integrative computation to define fundamental mechanisms regulating genes and cells and connect these with human physiology, pathology, and therapeutics.

Altius collaborates with an international network of scientists and its unique environment synergizes with major publicly-funded research efforts aiming to chart the functional genomic landscapes of human health and disease.

Center of Excellence in Genomic Science